Cargando…

Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms

The effects of the parasiticide ivermectin were assessed in plankton-dominated indoor microcosms. Ivermectin was applied once at concentrations of 30, 100, 300, 1000, 3000, and 10,000 ng/l. The half-life (dissipation time 50%; DT(50)) of ivermectin in the water phase ranged from 1.1 to 8.3 days. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonstra, Harry, Reichman, Erik P., van den Brink, Paul J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019351/
https://www.ncbi.nlm.nih.gov/pubmed/20422169
http://dx.doi.org/10.1007/s00244-010-9526-1
_version_ 1782196199745388544
author Boonstra, Harry
Reichman, Erik P.
van den Brink, Paul J.
author_facet Boonstra, Harry
Reichman, Erik P.
van den Brink, Paul J.
author_sort Boonstra, Harry
collection PubMed
description The effects of the parasiticide ivermectin were assessed in plankton-dominated indoor microcosms. Ivermectin was applied once at concentrations of 30, 100, 300, 1000, 3000, and 10,000 ng/l. The half-life (dissipation time 50%; DT(50)) of ivermectin in the water phase ranged from 1.1 to 8.3 days. The lowest NOEC(community) that could be derived on an isolated sampling from the microcosm study by means of multivariate techniques was 100 ng/l. The most sensitive species in the microcosm study were the cladocerans Ceriodaphnia sp. (no observed effect concentration, NOEC = 30 ng/l) and Chydorus sphaericus (NOEC = 100 ng/l). The amphipod Gammarus pulex was less sensitive to ivermectin, showing consistent statistically significant reductions at the 1000-ng/l treatment level. Copepoda taxa decreased directly after application of ivermectin in the highest treatment but had already recovered at day 20 posttreatment. Indirect effects (e.g., increase of rotifers, increased primary production) were observed at the highest treatment level starting only on day 13 of the exposure phase. Cladocera showed the highest sensitivity to ivermectin in both standard laboratory toxicity tests as well as in the microcosm study. This study demonstrates that simple plankton-dominated test systems for assessing the effects of ivermectin can produce results similar to those obtained with large complex outdoor systems.
format Text
id pubmed-3019351
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30193512011-02-08 Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms Boonstra, Harry Reichman, Erik P. van den Brink, Paul J. Arch Environ Contam Toxicol Article The effects of the parasiticide ivermectin were assessed in plankton-dominated indoor microcosms. Ivermectin was applied once at concentrations of 30, 100, 300, 1000, 3000, and 10,000 ng/l. The half-life (dissipation time 50%; DT(50)) of ivermectin in the water phase ranged from 1.1 to 8.3 days. The lowest NOEC(community) that could be derived on an isolated sampling from the microcosm study by means of multivariate techniques was 100 ng/l. The most sensitive species in the microcosm study were the cladocerans Ceriodaphnia sp. (no observed effect concentration, NOEC = 30 ng/l) and Chydorus sphaericus (NOEC = 100 ng/l). The amphipod Gammarus pulex was less sensitive to ivermectin, showing consistent statistically significant reductions at the 1000-ng/l treatment level. Copepoda taxa decreased directly after application of ivermectin in the highest treatment but had already recovered at day 20 posttreatment. Indirect effects (e.g., increase of rotifers, increased primary production) were observed at the highest treatment level starting only on day 13 of the exposure phase. Cladocera showed the highest sensitivity to ivermectin in both standard laboratory toxicity tests as well as in the microcosm study. This study demonstrates that simple plankton-dominated test systems for assessing the effects of ivermectin can produce results similar to those obtained with large complex outdoor systems. Springer-Verlag 2010-04-27 2011 /pmc/articles/PMC3019351/ /pubmed/20422169 http://dx.doi.org/10.1007/s00244-010-9526-1 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Boonstra, Harry
Reichman, Erik P.
van den Brink, Paul J.
Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title_full Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title_fullStr Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title_full_unstemmed Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title_short Effects of the Veterinary Pharmaceutical Ivermectin in Indoor Aquatic Microcosms
title_sort effects of the veterinary pharmaceutical ivermectin in indoor aquatic microcosms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019351/
https://www.ncbi.nlm.nih.gov/pubmed/20422169
http://dx.doi.org/10.1007/s00244-010-9526-1
work_keys_str_mv AT boonstraharry effectsoftheveterinarypharmaceuticalivermectininindooraquaticmicrocosms
AT reichmanerikp effectsoftheveterinarypharmaceuticalivermectininindooraquaticmicrocosms
AT vandenbrinkpaulj effectsoftheveterinarypharmaceuticalivermectininindooraquaticmicrocosms